InflaRx N.V. announced on September 12, 2025, that it has regained compliance with The Nasdaq Stock Market LLC's minimum bid price requirement. The company received a written notice from Nasdaq confirming its compliance with Listing Rule 5450(a)(1).
The compliance was achieved because the closing bid price of InflaRx's ordinary shares maintained $1.00 per share or greater for 10 consecutive business days, from August 27, 2025, to September 10, 2025. This resolution closes the matter of the deficiency notice received on July 11, 2025.
This development removes the immediate risk of delisting or transfer to another market, providing stability regarding the company's listing status on Nasdaq.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.